Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Witte, T.J.M. de"'
Autor:
Stauder, R., Yu, Ge, Koinig, Karin A., Bagguley, Timothy, Fenaux, P., Symeonidis, A., Langemeijer, S.M.C., Marrewijk, C.J. van, Droste, J.A.H., Bowen, D., Witte, T.J.M. de
Publikováno v:
Leukemia, 32, 1380-1392
Leukemia, 32, 6, pp. 1380-1392
Leukemia, 32, 6, pp. 1380-1392
Contains fulltext : 192212.pdf (Publisher’s version ) (Open Access)
Autor:
Varghese, J., Holz, C., Neuhaus, P., Bernardi, M., Boehm, A., Ganser, A., Gore, S., Heaney, M., Hochhaus, A., Hofmann, W.K., Krug, U., Muller-Tidow, C., Smith, A., Weltermann, A., Witte, T.J.M. de, Hehlmann, R., Dugas, M.
Publikováno v:
Studies in Health Technology and Informatics, 228, 282-6
Studies in Health Technology and Informatics, 228, pp. 282-6
Studies in Health Technology and Informatics, 228, pp. 282-6
Contains fulltext : 172875.pdf (Publisher’s version ) (Open Access) Data standards consisting of key data elements for clinical routine and trial documentation harmonize documentation within and across different health care institutions making docu
Autor:
Lubbert, M., Suciu, S., Hagemeijer, A., Ruter, B., Platzbecker, U., Giagounidis, A., Selleslag, D., Labar, B., Germing, U., Salih, H.R., Muus, P., Pfluger, K.H., Schaefer, H.E., Bogatyreva, L., Aul, C., Witte, T.J.M. de, Ganser, A., Becker, H., Huls, G.A., Helm, L. van der, Vellenga, E., Baron, F., Marie, J.P., Wijermans, P.W., Group, E.L., German, M.D.S.S.G. the
Publikováno v:
Annals of Hematology, 95(2), 191-199. SPRINGER
Annals of Hematology, 95, 191-199
Annals of Hematology, 95, 2, pp. 191-199
Annals of Hematology, 95, 191-199
Annals of Hematology, 95, 2, pp. 191-199
Item does not contain fulltext In a study of elderly AML patients treated with the hypomethylating agent decitabine (DAC), we noted a surprisingly favorable outcome in the (usually very unfavorable) subgroup with two or more autosomal monosomies (MK2
Autor:
Labar, B., Suciu, S., Zittoun, R., Muus, P., Marie, J.P., Fillet, G., Peetermans, M., Stryckmans, P., Willemze, R., Feremans, W., Jaksic, B., Bourhis, J., Burghouts, J.P., Witte, T.J.M. de
Publikováno v:
Haematologica, 89, 7, pp. 809-17
Haematologica, 89, 809-17
Haematologica, 89, 809-17
Contains fulltext : 58075.pdf (Publisher’s version ) (Open Access) BACKGROUND AND OBJECTIVES: In the EORTC ALL-3 trial, the efficacy of allogeneic transplantation was compared with that of autologous marrow transplantation and maintenance chemother
Autor:
Rijke, B. de, Fredrix, H., Zoetbrood, A., Scherpen, F., Witteveen, H.J., Witte, T.J.M. de, Wiel-van Kemenade, E. van de, Dolstra, H.
Publikováno v:
Blood, 102, 8, pp. 2285-91
Blood, 102, 2285-91
Blood, 102, 2285-91
Contains fulltext : 186319.pdf (Publisher’s version ) (Closed access) Tumor relapses in patients with precursor B-cell acute lymphoblastic leukemia (BALL) occur frequently after primary treatment. Therefore, development of additional treatment moda
Autor:
Sierra, J., Perez, W.S., Rozman, C., Carreras, E., Klein, J.P., Rizzo, J.D., Davies, S.M., Lazarus, H.M., Bredeson, C.N., Marks, D.I., Canals, C., Boogaerts, M., Goldman, J., Champlin, R.E., Keating, A., Weisdorf, D.J., Witte, T.J.M. de, Horowitz, M.M.
Publikováno v:
Blood, 100, 1997-2004
Blood, 100, 6, pp. 1997-2004
Blood, 100, 6, pp. 1997-2004
Item does not contain fulltext Allogeneic hematopoietic stem cell transplantation is the only curative therapy for myelodysplasia (MDS). To identify factors influencing transplantation outcome, we studied 452 recipients of HLA-identical sibling trans
Autor:
Witte, T.J.M. de
Publikováno v:
Clinical Lymphoma Myeloma & Leukemia, 11 Suppl 1, pp. S46-8
Clinical Lymphoma Myeloma & Leukemia, 11 Suppl 1, S46-8
Clinical Lymphoma Myeloma & Leukemia, 11 Suppl 1, S46-8
Contains fulltext : 95637.pdf (Publisher’s version ) (Closed access) Allogeneic stem cell transplantation (SCT) is the treatment of choice for young patients (age
Autor:
Greenberg, P.L., Anderson, J., Witte, T.J.M. de, Estey, E., Fenaux, P., Gupta, P., Hamblin, T., Hellstrom-Lindberg, E., List, A.F., Mufti, G.J., Neuwirtova, R., Ohyashiki, K., Oscier, D., Sanz, M.A., Willman, C.
Publikováno v:
Journal of Clinical Oncology, 18, 19, pp. 3447-3452
Journal of Clinical Oncology, 18, 3447-3452
Journal of Clinical Oncology, 18, 3447-3452
Item does not contain fulltext
Autor:
Cahn, J., Labopin, M., Sierra, J., Baise, D., Reiffers, J., Ferrant, A., Bergmann, L., Visani, G., Cornelissen, J.J.L.M., Witte, T.J.M. de, Bost, A., Frassoni, F., Gorin, M.B.
Publikováno v:
British Journal of Haematology, 110, 308-314. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 110, 308-314
British Journal of Haematology, 110, pp. 308-314
British Journal of Haematology, 110, 308-314
British Journal of Haematology, 110, pp. 308-314
Item does not contain fulltext
Autor:
Keating, S., Witte, T.J.M. de, Suciu, S., Mandelli, F., Damasio, E., Willemze, R., Morra, E., Amadori, S., Dardenne, M., Vegna, M.L., Zittoun, R.
Publikováno v:
European Journal of Cancer, 35, 1440-7
European Journal of Cancer, 35, 10, pp. 1440-7
European Journal of Cancer, 35, 10, pp. 1440-7
Item does not contain fulltext In the AML 8A study patients were treated with remission-induction therapy followed by one consolidation course. Patients in complete remission (CR) were randomised between autologous bone marrow transplantation (ABMT)